Business Can-Fite BioPharma stock rating downgraded to Hold by D. Boral Capital Published 3 hours ago on 24 December 2025 By NewsAdmin Can-Fite BioPharma stock rating downgraded to Hold by D. Boral Capital Source link Related Topics: Up Next 2026 Market Outlook: Valuation Expectations Are Far More Optimistic Than Analysts (SPY) Don't Miss Video Marketing Agency FMO Media Highlights Winning Marketing Approach in the Digital Space Continue Reading Advertisement You may like Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.